According to the SEC Form 4 filings, Hopson Ricky, being in a position of
The largest sale of all time was on 2022-01-31 and amounted to 2325 shares of Catalent, Inc. for $240,382.
No biography is available at this moment.
| 2024-08-02 | Sale | Catalent, Inc. CTLT | Pres. BioProduct Delivery, CoS | 662 0.0004% | $59.56 | $39,429 | +0.44% | |
| 2024-07-29 | Sale | Catalent, Inc. CTLT | Pres. BioProduct Delivery, CoS | 206 0.0001% | $58.67 | $12,086 | +1.37% | |
| 2024-06-04 | Sale | Catalent, Inc. CTLT | Pres. BioProduct Delivery, CoS | 1,401 0.0008% | $54.26 | $76,023 | +8.17% | |
| 2023-08-24 | Sale | Catalent, Inc. CTLT | Pres. Clinical Dev Supply Div | 276 0.0002% | $44.56 | $12,299 | +22.22% | |
| 2023-08-01 | Sale | Catalent, Inc. CTLT | Pres. Clinical Dev Supply Div | 195 0.0001% | $47.86 | $9,333 | +7.67% | |
| 2023-01-23 | Sale | Catalent, Inc. CTLT | Pres. Clinical Dev Supply Div | 643 0.0003% | $49.36 | $31,738 | -13.39% | |
| 2022-08-31 | Sale | Catalent, Inc. CTLT | Pres. Clinical Dev Supply Div | 2,216 0.0013% | $89.59 | $198,531 | -45.42% | |
| 2022-08-24 | Sale | Catalent, Inc. CTLT | Pres. Clinical Dev Supply Div | 1,517 0.0008% | $103.04 | $156,312 | -53.08% | |
| 2022-07-26 | Sale | Catalent, Inc. CTLT | Pres, Clinical Dev & Supply | 312 0.0002% | $106.90 | $33,353 | -52.83% | |
| 2022-01-31 | Sale | Catalent, Inc. CTLT | VP, Chief Accounting Officer | 2,325 0.0013% | $103.39 | $240,382 | -7.49% | |
| 2021-08-27 | Sale | Catalent, Inc. CTLT | VP, Chief Accounting Officer | 1,471 0.0009% | $131.13 | $192,894 | -15.41% | |
| 2021-07-26 | Sale | Catalent, Inc. CTLT | VP, Chief Accounting Officer | 360 0.0002% | $113.05 | $40,698 | -1.66% |